Halozyme Therapeutics, Inc. (HALO) Earnings Call Transcripts
About Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. (HALO) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 61 calls on record spanning January 16, 2020 to September 16, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 61 Halozyme Therapeutics, Inc. earnings call transcripts on record, spanning January 16, 2020 to September 16, 2026. Based on this history, Halozyme Therapeutics, Inc. reports quarterly. The most recent call on file is dated September 16, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- HALO
- Exchange
- NasdaqGS
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 61
- First call
- January 16, 2020
- Most recent
- September 16, 2026
- Reporting cadence
- quarterly